Resultado de búsqueda
30 de abr. de 2024 · INDIANAPOLIS , March 10, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced results from a first-of-its-kind study of lebrikizumab specifically designed for people with skin of color and moderate-to-severe atopic dermatitis, commonly called eczema.
- Investors
The Investor Relations website contains information about...
- Investors
Hace 5 días · Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
Hace 5 días · The U.S. Food and Drug Administration (FDA) will convene an in-person meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) on Monday, June 10, 2024, to discuss donanemab, which Eli Lilly and Company (NYSE: LLY) has submitted for the treatment of early symptomatic Alzheimer’s disease. The open public hearing portion of the meeting will be conducted virtually.
30 de abr. de 2024 · Eli Lilly es uno de los principales competidores de Novo Nordisk en el mercado de los antidiabéticos. Solo Mounjaro ya generó 1.810 millones de dólares en el primer trimestre de 2024.
30 de abr. de 2024 · Eli Lilly raised both ends of its 2024 revenue forecast by $2 billion and now expects $42.4 billion to $43.6 billion for the year. The drugmaker also raised its annual profit forecast by $1.30 per ...
Hace 6 días · Eli Lilly, una de las compañías farmacéuticas más grandes del mundo, está liderando un cambio revolucionario en el diseño de nuevos medicamentos mediante el uso de Inteligencia Artificial ...
